- Home
- LPG vs PRCT Comparison
LPG vs PRCT Comparison
Compare LPG & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | PRCT |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LPG | PRCT |
|---|---|---|
| Price | $36.20 | $20.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $39.33 | $35.44 |
| AVG Volume (30 Days) | 747.6K | ★ 1.8M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | ★ 112.15 | 1.71 |
| EPS | ★ 4.54 | N/A |
| Revenue | ★ $481,511,242.00 | $308,054,000.00 |
| Revenue This Year | $35.73 | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | $7.93 | ★ N/A |
| Revenue Growth | 36.27 | ★ 37.22 |
| 52 Week Low | $23.76 | $19.35 |
| 52 Week High | $48.12 | $62.17 |
Technical Indicators
Market Signals| Indicator | LPG | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 36.55 | 37.97 |
| Support Level | $24.30 | $20.18 |
| Resistance Level | $38.40 | $29.27 |
| Average True Range (ATR) | 1.81 | 1.71 |
| MACD | -0.73 | -0.07 |
| Stochastic Oscillator | 14.11 | 14.59 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.